Kristen L. Alexander
Chief Accounting Officer
Lexicon Pharmaceuticals, Inc. (LXRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kristen L. Alexander
Kristen L. Alexander is recorded as CFO and Chief Accounting Officer at Lexicon Pharmaceuticals, Inc. (LXRX). Lexicon Pharmaceuticals, Inc. reported in an 8-K filed September 16, 2024 that Kristen L. Alexander was appointed principal financial officer, effective September 30, 2024. The proxy statement of Lexicon Pharmaceuticals, Inc. reports total compensation of $613,245 for Kristen L. Alexander in fiscal 2024, including a base salary of $295,588. Disclosed compensation is on record for 3 fiscal years.
“Effective as of the date of termination of Mr. Wade's employment, Kristen L. Alexander will assume the function of our principal financial officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-30–present
-
Current
2021-09-24–present
-
Lexicon Pharmaceuticals, Inc. (LXRX)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexicon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Exton, Ph.D. CEO, Board Member
- Michael S. Exton CEO, Board Member
- Raymond Debbane Chairman
- Jeffrey L. Wade COO
- Christopher J. Sobecki Board Member
- Diane E. Sullivan Board Member
- Ivan H. Cheung Board Member
- Judith L. Swain Board Member
- Philippe J. Amouyal Board Member
- Samuel L. Barker Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lexicon Pharmaceuticals, Inc. (LXRX) | Vice President, Finance and Accounting | $295,588 | $613,245 |
| 2023 | Lexicon Pharmaceuticals, Inc. (LXRX) | Vice President, Finance and Accounting | $285,359 | $622,984 |
| 2022 | Lexicon Pharmaceuticals, Inc. (LXRX) | Vice President, Finance and Accounting | $269,867 | $588,751 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.